Acorn Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History
Acorn Wealth Advisors, LLC
- $222 Million
- Q1 2025
A detailed history of Acorn Wealth Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Acorn Wealth Advisors, LLC holds 2,363 shares of GILD stock, worth $274,580. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,363
Previous 2,349
0.6%
Holding current value
$274,580
Previous $216,000
22.22%
% of portfolio
0.12%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,294Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$14 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.92 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.35 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.22 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $146B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...